Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 83.29% is in line with its 5-year average of 78.23%, near the high end of its 5-year range (68.01%–87.93%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.82% above its 12-month average of 77.97%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 83.29%.
DEBT TO ASSETS RATIO
83.29%
DEBT TO ASSETS RATIO AVG TTM
77.97%
DEBT TO ASSETS RATIO AVG 3Y
77.58%
DEBT TO ASSETS RATIO AVG 5Y
78.23%
DEBT TO ASSETS RATIO AVG 10Y
77.06%
DEBT TO ASSETS RATIO AVG 15Y
52.96%
DEBT TO ASSETS RATIO AVG 20Y
39.88%
CURRENT VS TTM AVG
+6.82%
CURRENT VS 3Y AVG
+7.36%
CURRENT VS 5Y AVG
+6.46%
CURRENT VS 10Y AVG
+8.08%
CURRENT VS 15Y AVG
+57.27%
CURRENT VS 20Y AVG
+108.83%
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 465 covered companies
CURRENT VS SECTOR MEDIAN
+75615.74%
vs the sector median at left
Halozyme Therapeutics, Inc.
Market Cap
$12.85B
Debt to Assets Ratio
83.29%
TTM Avg
77.97%
3Y Avg
77.58%
5Y Avg
78.23%
Market Cap
$12.89B
Debt to Assets Ratio
0.21%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.95B
Debt to Assets Ratio
2.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.52B
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.19B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.17B
Debt to Assets Ratio
0.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.00B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.16B
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Halozyme Therapeutics, Inc. (HALO) | $12.85B | 83.29% | 77.97% | 77.58% | 78.23% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 0.21% | N/A | N/A | N/A |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | 2.05% | N/A | N/A | N/A |
| Baxter International Inc. (BAX)vs › | $12.52B | 0.49% | N/A | N/A | N/A |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 0.01% | N/A | N/A | N/A |
| Penumbra, Inc. (PEN)vs › | $12.49B | 0.11% | N/A | N/A | N/A |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 0.40% | N/A | N/A | N/A |
| Encompass Health Corporation (EHC)vs › | $12.00B | 0.38% | N/A | N/A | N/A |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | 0.20% | N/A | N/A | N/A |
| DaVita Inc. (DVA)vs › | $11.47B | 0.61% | N/A | N/A | N/A |
Debt/Assets
83.3%
Debt/Equity
14.95
Current Ratio
2.71
Interest Coverage
45.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 83.29% |
| 2026-03-31 | 80.24% |
| 2025-12-31 | 84.85% |
| 2025-09-30 | 68.01% |
| 2025-06-30 | 73.47% |
| 2025-03-31 | 68.63% |
| 2024-12-31 | 72.97% |
| 2024-09-30 | 71.02% |
| 2024-06-30 | 76.29% |
| 2024-03-31 | 81.50% |
| 2023-12-31 | 86.50% |
| 2023-09-30 | 79.13% |
| 2023-06-30 | 82.63% |
| 2023-03-31 | 87.93% |
| 2022-12-31 | 81.79% |
| 2022-09-30 | 80.69% |
| 2022-06-30 | 69.96% |
| 2022-03-31 | 75.51% |
| 2021-12-31 | 79.38% |
| 2021-09-30 | 73.87% |
| 2021-06-30 | 85.27% |
| 2021-03-31 | 90.40% |
| 2020-12-31 | 68.50% |
| 2020-09-30 | 75.12% |
| 2020-06-30 | 74.02% |
| 2020-03-31 | 79.10% |
| 2019-12-31 | 71.14% |
| 2019-09-30 | 17.24% |
| 2019-06-30 | 20.33% |
| 2019-03-31 | 24.56% |
| 2018-12-31 | 28.71% |
| 2018-09-30 | 32.95% |
| 2018-06-30 | 34.97% |
| 2018-03-31 | 37.37% |
| 2017-12-31 | 38.92% |
| 2017-09-30 | 57.92% |
| 2017-06-30 | 61.21% |
| 2017-03-31 | 94.38% |
| 2016-12-31 | 82.83% |
| 2016-09-30 | 75.11% |
| 2016-06-30 | 70.29% |
| 2016-03-31 | 63.42% |
| 2015-12-31 | 27.41% |
| 2015-09-30 | 31.37% |
| 2015-06-30 | 28.59% |
| 2015-03-31 | 31.24% |
| 2014-12-31 | 30.04% |
| 2014-09-30 | 30.27% |
| 2014-06-30 | 27.36% |
| 2014-03-31 | 25.19% |
| 2013-12-31 | 48.90% |
| 2013-09-30 | 29.33% |
| 2013-06-30 | 29.63% |
| 2013-03-31 | 26.64% |
| 2012-12-31 | 23.09% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 1757.84% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
